by Jim
Here is how Dr. Shiva A., MIT Biological Engineering PhD and developer of CytoSolve depicted it in early May;
We knew from the earliest in-vitro studies of infected cells that HCQ (along with Remdesivir) inhibited viral replication.. what was really cool I thought was the later data that came out showing that there was also dose-dependent inhibition of cellular entry via ACE2, which of course is a completely separate and complimentary mode of action. HCQ is in a sense a single molecule, “cocktail”.
Views: